Spectral Medical Inc (TSE:EDT) insider Debra-Anne Foster purchased 100,000 shares of the business’s stock in a transaction on Tuesday, February 11th. The shares were acquired at an average price of C$0.38 per share, for a total transaction of C$37,500.00. Following the completion of the purchase, the insider now directly owns 234,855 shares of the company’s stock, valued at C$88,070.63.
Shares of TSE:EDT opened at C$0.75 on Friday. The company has a debt-to-equity ratio of 21.26, a current ratio of 4.24 and a quick ratio of 3.64. The firm has a market capitalization of $155.81 million and a PE ratio of -57.69. The firm’s 50-day moving average is C$0.75 and its two-hundred day moving average is C$0.55. Spectral Medical Inc has a 1 year low of C$0.30 and a 1 year high of C$0.85.
Spectral Medical (TSE:EDT) last issued its quarterly earnings results on Thursday, November 14th. The company reported C($0.01) earnings per share (EPS) for the quarter. The business had revenue of C$0.53 million for the quarter. Analysts expect that Spectral Medical Inc will post -0.06 EPS for the current fiscal year.
Spectral Medical Inc focuses on the development and commercialization of treatment for septic shock in North America. The company markets Endotoxin Activity Assay, a rapid diagnostic test for the detection of components of gram negative bacterial cell wall in Europe and Canada; and Toraymyxin, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream in Europe, Canada, and Japan.
Read More: What is the S&P/TSX Index?
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.